Coating titanium implants with bioglass and with hydroxyapatite: A comparative study in sheep

Por Lopez-Sastre, A., Gonzalo-Orden, J. M., Altónaga, J. A. R., Altónaga, J. R., Orden, M. A.
Publicado em 1998

Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organ...

Por Fernandez-Bueno, I., Garcia-Gutierrez, M.T., Srivastava, G.K., Gayoso, M.J., Gonzalo-Orden, J.M., Pastor, J.C.
Publicado em 2013